BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 8786020)

  • 1. Alterations of glomerular basement membrane charge and structure in diabetic nephropathy.
    Goode NP; Shires M; Crellin DM; Aparicio SR; Davison AM
    Diabetologia; 1995 Dec; 38(12):1455-65. PubMed ID: 8786020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of heparan sulphate-associated anionic sites in the glomerular basement membrane of rats with streptozotocin-induced diabetic nephropathy.
    van den Born J; van Kraats AA; Bakker MA; Assmann KJ; Dijkman HB; van der Laak JA; Berden JH
    Diabetologia; 1995 Oct; 38(10):1169-75. PubMed ID: 8690168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective proteinuria in diabetic nephropathy in the rat is associated with a relative decrease in glomerular basement membrane heparan sulphate.
    van den Born J; van Kraats AA; Bakker MA; Assmann KJ; van den Heuvel LP; Veerkamp JH; Berden JH
    Diabetologia; 1995 Feb; 38(2):161-72. PubMed ID: 7713310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ultrastructural disruption of the glomerular basement membrane in diabetic nephropathy revealed by "tissue negative staining method".
    Ota K; Ota Z; Shikata K; Makino H
    J Diabetes Complications; 1995; 9(4):285-7. PubMed ID: 8573748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular matrix in human diabetic nephropathy: reduced expression of heparan sulphate in skin basement membrane.
    van der Pijl JW; Daha MR; van den Born J; Verhagen NA; Lemkes HH; Bucala R; Berden JH; Zwinderman AH; Bruijn JA; van Es LA; van der Woude FJ
    Diabetologia; 1998 Jul; 41(7):791-8. PubMed ID: 9686920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructural changes of extracellular matrices in diabetic nephropathy revealed by high resolution scanning and immunoelectron microscopy.
    Makino H; Yamasaki Y; Haramoto T; Shikata K; Hironaka K; Ota Z; Kanwar YS
    Lab Invest; 1993 Jan; 68(1):45-55. PubMed ID: 8423676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced content and abnormal distribution of anionic sites (acid proteoglycans) in the diabetic glomerular basement membrane.
    Rohrbach R
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 51(2):127-35. PubMed ID: 2425479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparan sulfate proteoglycan in the glomerular basement membrane in type 1 diabetes mellitus.
    Vernier RL; Steffes MW; Sisson-Ross S; Mauer SM
    Kidney Int; 1992 Apr; 41(4):1070-80. PubMed ID: 1513088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathobiochemical aspects of diabetic nephropathy.
    Schleicher E; Nerlich A; Gerbitz KD
    Klin Wochenschr; 1988 Sep; 66(18):873-82. PubMed ID: 2972877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retention of glomerular basement membrane-proteoglycans accompanying loss of anionic site staining in experimental diabetes.
    Templeton DM
    Lab Invest; 1989 Aug; 61(2):202-11. PubMed ID: 2755078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane.
    Tamsma JT; van den Born J; Bruijn JA; Assmann KJ; Weening JJ; Berden JH; Wieslander J; Schrama E; Hermans J; Veerkamp JH
    Diabetologia; 1994 Mar; 37(3):313-20. PubMed ID: 8174847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of glomerular anionic charge status in children with IgA nephropathy using confocal laser scanning microscopy.
    Sakagami Y; Nakajima M; Takagawa K; Ueda T; Akazawa H; Maruhashi Y; Shimoyama H; Kamitsuji H; Yoshioka A
    Nephron Clin Pract; 2004; 96(3):c96-104. PubMed ID: 15056992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes of glomerular basement membrane components in Vacor-induced diabetic nephropathy.
    Seon YD; Lee TH; Lee MC
    Korean J Intern Med; 1999 Jan; 14(1):77-84. PubMed ID: 10063318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical quantification of heparan sulfate proteoglycan and collagen IV in skeletal muscle capillary basement membranes of patients with diabetic nephropathy.
    Yokoyama H; Høyer PE; Hansen PM; van den Born J; Jensen T; Berden JH; Deckert T; Garbarsch C
    Diabetes; 1997 Nov; 46(11):1875-80. PubMed ID: 9356039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newly diagnosed insulin-dependent diabetes mellitus with rapid severe thickening of the glomerular basement membrane.
    Miyatake N; Shikata K; Maruyama K; Sugimoto H; Makino H
    Nephron; 1998 Sep; 80(1):100-1. PubMed ID: 9730721
    [No Abstract]   [Full Text] [Related]  

  • 16. Diabetic glomerulosclerosis--immunogold ultrastructural studies on the glomerular distribution of type IV collagen and heparan sulphate proteoglycan.
    Woodrow D; Moss J; Shore I; Spiro RG
    J Pathol; 1992 May; 167(1):49-58. PubMed ID: 1625058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sorbinil does not prevent galactose-induced glomerular capillary basement membrane thickening in the rat.
    Das A; Frank RN; Zhang NL
    Diabetologia; 1990 Sep; 33(9):515-21. PubMed ID: 2123806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions.
    Nerlich A; Schleicher E
    Am J Pathol; 1991 Oct; 139(4):889-99. PubMed ID: 1928305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The relation between the changes of width and anionic sites of glomerular basement membrane and transferrinuria in rats].
    Chen Y; Qian Y
    Zhonghua Yi Xue Za Zhi; 1995 Sep; 75(9):537-9, 574. PubMed ID: 8556544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Electron microscopic study of the glomerular basement membrane charge barrier and the charge of immune deposits in lupus nephritis].
    Tochimaru H
    Hokkaido Igaku Zasshi; 1991 Nov; 66(6):829-40. PubMed ID: 1783370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.